Description: - A collection of 575 highly selective inhibitors;- Covering 170 drug targets;- Some inhibitors have been approved by FDA;- Covering a variety of signaling pathways, such as ion channels; NF-κB; PI3K/Akt/mTOR signaling; MAPK and so on.- Diverse structure, strong biological activity, cell penetrable;- Detailed specifications, compound structure, target information, IC50 value, activity description, etc;- NMR, HPLC/LCMS and other detection techniques to ensure the correct structure, high purity of the product and to reduce false positives.